From: Anesthesia quality indicators to measure and improve your practice: a modified delphi study
Indicator | n/14 | % | Donabedian Quality Classification |
---|---|---|---|
Airway complications (greater than 3 attempts at intubation, cannot intubate/cannot ventilate, laryngospasm, hypoxia, dental/soft tissue injury)∗ | 13 | 93 | Process & Outcome |
Incidence & duration of perioperative adverse events including hypoxia, hyper/hypocarbia, hyper/hypothermia, hyper/hypoglycemia, anesthetic overdose∗ Degree & duration of hypotension on induction (SBP < 80) ∗ | 12 10 | 86 71 | Outcome Outcome |
Number of medical errors (patient receiving wrong drug, drug dose, wrong surgical site, wrong blood product etc) Medication error with wrong medication or wrong dose given Number of wrong site or side procedures | 11 10 1 | 79 71 < 1 | Process Process Process/Structure? |
Patient satisfaction (composite patient experience) | 11 | 79 | Outcome |
Postoperative residual neuromuscular blockade (ToF < 0.9 measured 15 min after arrival to PACU, clinical residual weakness) requiring intervention by an anesthesiologist to treat inadequate reversal of neuromuscular blockade∗ | 10 | 71 | Outcome |
Temperature less than 35.5 Celsius on arrival to PACU∗ | 10 | 71 | Outcome |
Complications of neuraxial block (failed block, inadvertent dural puncture, high block, infection, neurologic complication etc) ∗ Inadequate regional/neuraxial block requiring supplemental analgesia, sedation or conversion to GA required for surgery∗ Epidural or neuraxial technique not working as planned, inadequate pain coverage necessitating additional interventions | 9 6 2 | 64 43 14 | Outcome Outcome/Process Outcome |
Incidence of severe postoperative nausea and vomiting (2 or more episodes of severe nausea/vomiting over 6 hours apart OR requiring more than 2 doses of antiemetics; patients who receive an intervention by an anesthesiologist for PONV not responding to PACU protocols in the recovery period) ∗ | 9 | 64 | Outcome |
Complications of central venous line placement (arterial puncture, pneumothorax, nerve injury, infection, etc) ∗ | 8 | 57 | Outcome |
Intervention required by an anesthesiologist in PACU to relieve respiratory distress∗ | 8 | 57 | Outcome & Process |
Perioperative cardiac complications (arrhythmia, ischemia, myocardial infarction) ∗ | 7 | 50 | Outcome |
Adequacy of postoperative pain management (pain scores at defined intervals, plan documentation, care pathway milestones, etc) ∗ | 7 | 50 | Outcome |
All cause complications within 30 days or until hospital discharge or death | 7 | 50 | Outcome |
Proportion of patients receiving appropriate surgical antibiotic prophylaxis∗ | 7 | 50 | Process & Structure |
Unplanned overnight admission of day surgery patients for anesthetic reasons | 7 | 50 | Outcome |
Pain scores on arrival to PACU∗ | 7 | 50 | Outcome |
Cerebrovascular accident developing during or within 48h of anesthetic care | 6 | 43 | Outcome |
Monitoring hand hygiene (direct observation or mechanical monitoring) | 6 | 43 | Process & Structure |
Adequate perioperative management of patient’s current medications | 6 | 43 | Process |
Incidence of intraoperative awareness | 6 | 43 | Outcome |
Incidence of delirium during the postoperative period | 6 | 43 | Outcome |
Patient requiring an intervention by an anesthesiologist for circulatory/hemodynamic reasons in the recovery period∗ | 5 | 36 | Outcome |
Critical incident reviews for rare and infrequently occurring events | 5 | 36 | Process & Structure |
Ultrasound used for vascular access procedures∗ | 5 | 36 | Process |
Unplanned admission to ICU or high dependency unit within 24h of a procedure involving anesthesiology | 5 | 36 | Outcome |
Proportion of charts with documentation of informed consent and risks on anesthetic technique∗ | 4 | 29 | Process & Structure |
Patients developing severe respiratory depression requiring naloxone administration during acute pain management∗ | 4 | 29 | Outcome & Process |
Unplanned extended PACU stay for medical reasons | 4 | 29 | Outcome |
Adherence to care pathway processes (eg. ERAS or fast track protocols) | 4 | 29 | Process |
Percentage of cases receiving PONV prophylaxis∗ | 4 | 29 | Process |
Renal insufficiency (25% increase in serum creatinine or absolute increase > 44umol/L at any time within the first 5 postop days) or renal failure (doubling of serum creatinine or oliguria < 500ml/24h developing during or within 48h or anesthetic care) | 4 | 29 | Outcome |
Visual loss or eye injury∗ | 3 | 21 | Outcome |
360 degree evaluation | 3 | 21 | Structure & Process |
ASA physical status class∗ | 3 | 21 | N/A |
Time to patient orientation (able to correctly answer name and whereabouts) | 3 | 21 | Outcome |
Surgical safety checklist completed before induction∗ | 2 | 14 | Process & Structure |
Preoperative patient anxiety adequately addressed by anesthesiologist (eg. Bauer questionnaire 24h postop) | 2 | 14 | Outcome & Process |
Caseload breakdown by anesthetic technique (GA, neuraxial, regional, sedation, local, none, etc) ∗ | 2 | 14 | Process |
Adverse drug reaction other than anaphylaxis∗ | 2 | 14 | Outcome |
Transfusion-related complications (volume overload, TRALI, ABO incompatibility) | 2 | 14 | Outcome |
Noncardiogenic pulmonary edema during or within 48h or anesthetic care | 2 | 14 | Outcome |
Surgical service∗ | 2 | 14 | N/A |
Surgical priority (emergent, urgent, elective) ∗ | 2 | 14 | N/A |
Surgical caseload (time of day, day of week) ∗ | 2 | 14 | N/A |
Number of GA cases using neuromuscular blockade where reversal was given intraoperatively∗ | 2 | 14 | Process |
Epidural or neuraxial technique not working as planned, inadequate pain coverage necessitating additional interventions | 2 | 14 | Outcome |
General anesthetic given for a Cesarean section∗ | 1 | < 1 | Process |
Proportion of patient with clearly documented transfer of care immediately postoperatively to a PACU or ICU (eg. checklist) ∗ | 1 | < 1 | Process |
Incidence of local anesthetic toxicity∗ | 0 | 0 | Outcome |
Number of patients receiving a blood transfusion in OR or PACU∗ | 0 | 0 | Outcome |
Number of cases where PACU was bypassed∗ | 0 | 0 | Process & Structure |